Dacliximab- Biopharmaceuticals
Drug Name:
Dacliximab- Biopharmaceuticals
List Of Brands:
Indication Type Description:
Indication:
Immunosuppressants
Patent Expiry Date of drugs (Ref - IDMA Publication)
Chemical Category Manufacturer/ US Patent
Ingredient- Marketer Expiration Date
Dacliximab Biopharmaceuticals Protein Design 25-06-2013